Genzyme regulatory update

GENZ will conduct a confirmatory Phase III trial of the adjunct to radioiodine scanning. The trial is anticipated to start in the first quarter, and GENZ expects to file an NDA in 1996. The number of patients to be enrolled in the trial has not been determined. ...